Ultan McDermott
AstraZeneca (United Kingdom)(GB)University of Cambridge(GB)Cambridge University Hospitals NHS Foundation Trust(GB)Wellcome Sanger Institute(GB)AstraZeneca (Singapore)(SG)AstraZeneca (Brazil)(BR)Genomics (United Kingdom)(GB)Addenbrooke's Hospital(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Computational Drug Discovery Methods, Lung Cancer Treatments and Mutations, Chronic Myeloid Leukemia Treatments, Protein Degradation and Inhibitors
Most-Cited Works
- → Signatures of mutational processes in human cancer(2013)10,017 cited
- → Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells(2012)4,219 cited
- → A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations(2010)2,690 cited
- → Systematic identification of genomic markers of drug sensitivity in cancer cells(2012)2,534 cited
- → Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients(2015)2,383 cited
- → COSMIC: exploring the world's knowledge of somatic mutations in human cancer(2014)2,374 cited